Markets
Drugs Made In America Acquisition Corp. (DMAA)
DMAANASDAQ-GMN/A
$10.90
0.0000 (0.00%) today
Regular session, Nov 17, 10:00 AM ET
0.00% 1D
- Market cap
- –
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $10.90 to $10.91
- 52-week range
- $10.32 to $10.91
- Average volume
- –
- Previous close
- $10.90
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$264.0k | -$2.09m | -$143.0k | -$137.0k |
| Net income | $2.19m | $213.0k | $1.97m | $1.73m |
News
8 latest- Stocks Pressured by Weakness in Software and Health Insurance StocksBarchart · 5 minutes ago
- Stock Indexes Settle Sharply Lower on Big Tech DrubbingBarchart · 5 minutes ago
- MAIA Biotechnology Reports Consistent Strong Efficacy in Expanded Phase 2 THIO-101 Study in Non-Small Cell Lung CancerFintel · 20 minutes ago
- Boxlight Corporation Reports Third Quarter 2026 Financial Results with Gross Margin Expansion to 37.1% and Narrowed Net Loss of $1.0 MillionFintel · 20 minutes ago
- MetaVia Inc. Announces Completion of Last Patient Visit in Phase 1 Study of DA-1726Fintel · 20 minutes ago
- Not Nvidia. Not Broadcom. This Is the AI Chip Stock I’d Buy Before the Year Ends.The Motley Fool · 20 minutes ago
- Kyntra Bio (KYNB) Q3 2026 Earnings Call TranscriptThe Motley Fool · 22 minutes ago
- Marvell and Intel Are Both Down at Least 50% From Their 2026 Highs. Only 1 Is a Stock I’d Buy.The Motley Fool · 35 minutes ago
The company
- Sector
- N/A
- Industry
- N/A
- Exchange
- NASDAQ-GM
- Region
- North America
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.